gangrene
Enable an agent to recognise and document suspected or confirmed gangrene, assess threatened tissue and systemic deterioration, and support timely clinician-led decisions.
Research draft, second pass
A second pass drafted this model: the structure a model of this thing needs, and what is known about it in the world. The line under this one says how the second half was obtained - researched against sources, or recalled without web access, in which case nothing here was read anywhere and every claim is a lead to verify. Unreviewed either way.
recalled by Codex without web access - no source was read
Researched by: Codex
Purpose and description
Enable an agent to recognise and document suspected or confirmed gangrene, assess threatened tissue and systemic deterioration, and support timely clinician-led decisions.
Gangrene is tissue necrosis caused by critically impaired blood supply, destructive infection, or both, most often affecting the extremities but also occurring in internal organs.
It can be Assemble a time-stamped record of tissue findings and their diagnostic provenance.; Compare serial assessments to flag extension, new infection concerns or systemic deterioration.; Link gangrenous tissue to documented perfusion deficits, infection evidence and contributing conditions.; Route suspected gangrene for urgent clinical assessment; the NHS advises immediate emergency assessment when gangrene is suspected. [NHS: Gangrene](https://www.nhs.uk/conditions/gangrene/); Track clinician-directed decisions about tissue removal, blood-supply restoration and infection treatment. [NHS: Gangrene](https://www.nhs.uk/conditions/gangrene/); Expose missing evidence and unresolved tissue viability before a decision is treated as settled..
Distinguishing features
Require evidence of tissue death or an explicit suspicion of it; reduced blood flow alone establishes ischemia, not confirmed gangrene.
Treat discoloration, coldness, numbness, swelling and discharge as supporting observations rather than individually decisive tests. [NHS: Gangrene](https://www.nhs.uk/conditions/gangrene/)
Distinguish gangrene from uncomplicated cellulitis or an ulcer by documenting the evidence for nonviable tissue and its extent.
Do not infer clostridial gas gangrene from tissue gas alone: other organisms can produce gas, and suspected clostridial myonecrosis requires urgent clinical assessment. [IDSA: Skin and soft tissue infection guideline](https://www.idsociety.org/practice-guideline/skin-and-soft-tissue-infections/)
Keep anatomical labels separate from mechanism and morphology; a named presentation must not automatically determine the organism, tissue depth or perfusion state.
Scope
+ Suspected and confirmed gangrene affecting external tissues or internal organs
+ Dry, wet and gas gangrene descriptors, with evidence and uncertainty recorded separately
+ Location, depth, extent and viability of affected and adjacent tissue
+ Contributions from impaired perfusion, infection and local injury
+ Progression, systemic complications and clinician-directed management decisions
- Complete models of diabetes, peripheral arterial disease and other predisposing conditions
- General necrosis, infarction and wounds without a gangrene assessment
- Full organism taxonomy and antimicrobial pharmacology
- Standalone sepsis and shock management protocols
- Detailed surgical techniques, prosthetic design and rehabilitation programmes
Characteristics
- Diagnostic status
- suspected | confirmed | excluded | unresolved; assessor, timestamp and evidence Prevents an observation or provisional label from becoming an unsupported diagnosis.
- Anatomical distribution
- body site, laterality, organ, tissue compartment and multiplicity Locates the lesion and identifies which clinical service and neighbouring structures are relevant.
- Gangrene descriptors
- dry | wet | gas gangrene suspected | gas gangrene confirmed | mixed | unclassified; attributed terminology Preserves clinical distinctions without forcing every presentation into one exclusive subtype.
- Nonviable tissue extent
- length and depth in cm, area in cm² where appropriate, or organ-specific extent; method and timestamp Supports assessment of spread and planning while acknowledging limits of surface measurement.
- Adjacent tissue viability
- viable | threatened | nonviable | indeterminate; assessment method Separates established tissue loss from tissue potentially amenable to preservation.
- Perfusion evidence
- test-specific results, such as pressure in mmHg, pressure ratios or imaging findings; site and interpretation Records the evidence informing assessment of blood supply and potential restoration.
- Infection assessment
- suspected | supported | not currently supported | unknown; specimen, organism and sampling context when available Separates clinical infection assessment from isolated microbiological results.
- Progression
- new | stable on serial assessment | extending | recurrent | indeterminate; observation interval Makes change over time explicit rather than inferred from a single examination.
- Systemic complication status
- linked assessments of sepsis, shock or organ dysfunction; suspected or confirmed Connects local tissue injury to whole-person deterioration without duplicating those models.
- Management status
- awaiting specialist assessment | intervention planned | intervention underway | reassessment | recovery | comfort-focused care Shows the responsible team, pending decisions and agreed goals.
Also called
Where this came from
wikidata · CC0 1.0
Drafted structure
Bundle to layer to finding to question, as the second pass will find it: 6 bundles · 11 layers · 18 findings · 28 questions.
Gangrene identification Establish what the gangrene label refers to and how strongly it is supported.
Ischemia, discoloration and necrosis-related labels must not be collapsed into an unqualified gangrene diagnosis.
Tissue death evidence
Record the basis for suspected or established nonviability.
Basis of gangrene assessment
Keep direct examination, operative observations, imaging and pathology distinguishable, with assessor and date.
- What evidence supports tissue death rather than ischemia or discoloration alone? boundary
- Who assessed the tissue, when, and using which examination or investigation? provenance
Presentation classification
Separate morphology, anatomical naming and suspected infectious mechanism.
Qualified gangrene descriptors
Record the clinician's terminology and its supporting observations without allowing the label to supply missing evidence.
- Which observations support the recorded dry, wet, gas or mixed descriptor? definition
- If gas gangrene is recorded, what supports clostridial myonecrosis beyond the presence of gas? boundary
Anatomy and viability Represent the location and extent of dead tissue and the surrounding tissue at risk.
A surface lesion and a deep or internal lesion require different evidence to establish their true extent.
Affected tissue map
Describe each affected site and tissue compartment.
Distribution and depth
Document visible involvement separately from suspected or demonstrated deeper involvement.
- Which sites, sides, organs and tissue compartments are involved? measurement
- How was the extent measured, and what involvement remains inaccessible to that method? measurement
Viability at the margin
Capture the assessed transition between nonviable, threatened and viable tissue.
Adjacent tissue assessment
Keep uncertainty about surrounding tissue explicit and attributable to a clinical assessment.
- Which adjacent tissues are judged viable, threatened or indeterminate, and on what evidence? boundary
- What reassessment is needed before the proposed tissue-preservation or removal decision? action
Perfusion and infection Represent the interacting mechanisms behind this gangrene episode.
Management depends on the actual perfusion and infection findings, not merely on the word gangrene.
Blood supply failure
Connect affected tissue to evidence of impaired perfusion and its attributed cause.
Perfusion deficit and cause
Record site-specific perfusion evidence and distinguish demonstrated causes from background risk factors.
- What examination, pressure measurement or vascular imaging supports inadequate perfusion at this site? measurement
- Which vascular event, compression, injury or underlying condition is implicated, and how certain is that attribution? provenance
Infectious involvement
Characterise clinical and microbiological evidence of infection in the affected tissue.
Infection evidence and organisms
Interpret microbiology with specimen depth, collection timing and prior treatment rather than equating any positive sample with invasive infection.
- What supports invasive infection, and which tissue compartments are thought to be involved? boundary
- Where and when were specimens obtained, what was detected, and had antimicrobial treatment already started? provenance
Progression and urgency Assess local extension and whole-person deterioration over time.
An apparently limited lesion must be interpreted alongside its trajectory and systemic effects.
Local trajectory
Compare observations of lesion extent, tissue appearance, sensation and pain.
Serial change
Record changes against dated observations, retaining uncertainty when examinations are not comparable.
- Over what interval have the affected area, swelling, discharge, pain or sensation changed? measurement
- Do the observations support stability or extension, and were they collected by comparable methods? boundary
Systemic deterioration
Link local gangrene to current systemic assessment and escalation responsibility.
Urgent assessment and escalation
Track emergency assessment and specialist involvement. Suspected gas gangrene warrants urgent surgical exploration and debridement under IDSA guidance. [IDSA guideline](https://www.idsociety.org/practice-guideline/skin-and-soft-tissue-infections/)
- What current observations support suspected sepsis, shock or organ dysfunction? measurement
- Which team has accepted urgent assessment, and is any pending investigation delaying required intervention? action
Intervention and residual state Track clinical decisions and the tissue state remaining after intervention.
Removing dead tissue, addressing its causes and preserving remaining function are distinct objectives.
Tissue-directed decisions
Represent proposed and completed interventions with their clinical rationale.
Intervention rationale
Record decisions concerning debridement, amputation, perfusion restoration and infection treatment, including goals and responsible clinicians.
- Which interventions are proposed or completed, and what tissue, perfusion or infection findings justify them? action
- How do assessed tissue viability, clinical feasibility and the person's goals shape the plan? action
Post-intervention tissue state
Assess residual nonviability, ongoing causes and resulting tissue loss.
Residual disease and function
Distinguish control of the gangrene episode from wound healing and recovery of function.
- What evidence shows residual or recurrent necrosis, persistent infection or inadequate perfusion? measurement
- What tissue loss, healing needs and functional consequences require follow-up or linked rehabilitation records? action
Evidence and external alignment What the world already says about this thing, gathered so the model can be checked against it.
A model that cannot be lined up against existing standards, identifiers and practice cannot be adopted by anyone who already uses them.
Reported evidence
Findings from the breadth pass, kept separate from the structural claims.
Check these first
Recalled without web access and unsourced; every item is a lead to verify.
- This describes the medical condition; no alternative sense was supplied.
- The listed kinds overlap: dry and wet describe clinical appearance, whereas gas and Fournier gangrene identify infectious or anatomical patterns.
- Recalled information only; verify current coding rules and disease-specific exclusions before using I96.
- Which of these check these first hold for the sense of gangrene this model covers, and on what evidence? provenance
Kinds and varieties
Recalled without web access and unsourced; every item is a lead to verify.
- Dry gangrene
- Wet gangrene
- Gas gangrene, typically clostridial myonecrosis
- Fournier gangrene, a necrotizing infection of the perineal, genital or perianal tissues
- Which of these kinds and varieties hold for the sense of gangrene this model covers, and on what evidence? provenance
Identifiers and schemes
Recalled without web access and unsourced; every item is a lead to verify.
- ICD-10 - I96 - World Health Organization category for gangrene, not elsewhere classified; gangrene associated with particular diseases or infections may require other codes.
- Which of these identifiers and schemes hold for the sense of gangrene this model covers, and on what evidence? provenance
Real-world use
Recalled without web access and unsourced; every item is a lead to verify.
- Recognition of irreversible tissue injury in vascular surgery, emergency medicine and wound care.
- Assessment of complications of peripheral arterial disease and diabetes-related foot disease.
- Distinguishing ischemic tissue loss from rapidly spreading necrotizing infection.
- Documentation of tissue loss and infection when planning revascularization, debridement or amputation.
- Which of these real-world use hold for the sense of gangrene this model covers, and on what evidence? provenance
Typical measurements
Recalled without web access and unsourced; every item is a lead to verify.
- Extent of affected tissue - No universal range; documented by anatomical distribution, wound dimensions and depth. - cm or cm² for wound dimensions or area
- Which of these typical measurements hold for the sense of gangrene this model covers, and on what evidence? provenance
Failure modes and hazards
Recalled without web access and unsourced; every item is a lead to verify.
- Permanent tissue loss, potentially requiring amputation.
- Secondary infection of initially dry gangrene.
- Rapid spread of infection and tissue destruction in wet or gas gangrene.
- Sepsis, shock, multiorgan failure and death.
- Delayed recognition when neuropathy reduces pain or affected tissue is not readily visible.
- Which of these failure modes and hazards hold for the sense of gangrene this model covers, and on what evidence? provenance
Regional variation
Recalled without web access and unsourced; every item is a lead to verify.
- Underlying causes and outcomes vary with the prevalence of diabetes and peripheral arterial disease and with access to vascular, surgical and infection care.
- Diagnostic coding varies between the WHO ICD classification and national modifications.
- Which of these regional variation hold for the sense of gangrene this model covers, and on what evidence? provenance
Neighbouring kinds and how to tell them apart
Recalled without web access and unsourced; every item is a lead to verify.
- Necrosis - Necrosis is the broader category of cell or tissue death; gangrene describes particular clinical patterns of tissue necrosis associated with ischemia or destructive infection.
- Ischemia - Ischemia is inadequate blood supply and can be reversible; gangrene entails established tissue death.
- Necrotizing fasciitis - Necrotizing fasciitis is an infection spreading through fascia and adjacent soft tissue; gangrene can arise without infection, although Fournier gangrene is a form of necrotizing fasciitis.
- Cellulitis - Cellulitis is an infection of the skin and subcutaneous tissue that does not, by definition, entail tissue necrosis.
- Frostbite - Frostbite is freezing injury that can cause gangrene; gangrene is the resulting tissue-death pattern rather than the cold exposure injury itself.
- Which of these neighbouring kinds and how to tell them apart hold for the sense of gangrene this model covers, and on what evidence? provenance
What the second pass must settle
- Which operational definitions should govern dry, wet and mixed gangrene across vascular surgery, infectious disease and pathology records?
- What evidence is sufficient to confirm gangrene at each external or internal site when operative or histological confirmation is unavailable?
- Which extent and viability measures are sufficiently comparable for serial assessment, particularly across skin tones and in people with impaired sensation?
- How should Fournier gangrene and organ-specific gangrenous conditions link to this entry and neighbouring models without creating duplicate sources of truth?
- Which site-specific criteria establish episode resolution when a wound, perfusion deficit or functional impairment persists?